Project Oncology®

187 Afleveringen

1. Exploring the Impacts of Race & Bias in Cancer Treatment

   Gepubliceerd: 12-1-2021
2. Systemic Racism & Disparities in Oncology

   Gepubliceerd: 12-1-2021
3. Assessing Advancements in Treatment Options for Small Cell Lung Cancer

   Gepubliceerd: 6-1-2021
4. Exploring the Treatment Landscape for Head & Neck Cancer

   Gepubliceerd: 23-12-2020
5. How COVID-19 Has Changed the Way We Approach Head & Neck Cancer Care

   Gepubliceerd: 23-12-2020
6. The COVID-19 Pandemic & Dangerous Delays in Cancer Screenings

   Gepubliceerd: 21-12-2020
7. HIPEC: A Novel Treatment for Advanced Abdominal Cancers

   Gepubliceerd: 23-1-2020
8. Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines

   Gepubliceerd: 12-7-2018
9. Not Quite a Cancer Vaccine: Selling HPV & Cervical Cancer

   Gepubliceerd: 19-2-2018
10. What to Know About a State-of-the-Art Approach to GIST Treatment

    Gepubliceerd: 17-1-2018
11. FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer

    Gepubliceerd: 7-1-2018
12. CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer

    Gepubliceerd: 23-10-2017
13. Pancreatic Cancer: The Hunt to Catch a Silent Killer

    Gepubliceerd: 12-8-2017
14. FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer

    Gepubliceerd: 28-7-2017
15. FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer

    Gepubliceerd: 25-7-2017
16. Linking p53 Variation to Breast Cancer Risk in African American Women

    Gepubliceerd: 19-6-2017
17. FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval

    Gepubliceerd: 30-5-2017
18. Pancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches

    Gepubliceerd: 23-5-2017
19. FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma

    Gepubliceerd: 22-5-2017
20. FDA D.I.S.C.O.: Niraparib in Ovarian Cancer

    Gepubliceerd: 18-5-2017